Literature DB >> 10747162

Identification of an epitope common to genogroup 1 "norwalk-like viruses".

A D Hale1, T N Tanaka, N Kitamoto, M Ciarlet, X Jiang, N Takeda, D W Brown, M K Estes.   

Abstract

A panel of 10 monoclonal antibodies (MAbs) to recombinant Norwalk virus (NV) capsid protein were tested in competition enzyme-linked immunosorbent assays. Patterns of competition indicated that these MAbs recognize six to eight epitopes covering five nonoverlapping regions of the capsid protein. A single epitope, recognized by NV MAbs NV3901, NV3912, and NV2461 was found to occur in the majority of genogroup 1 (G1) but not genogroup 2 (G2) "Norwalk-like viruses" (NLVs). This observation supports the subdivision of human NLVs into two genogroups and provides an assay for the rapid identification of G1 NLVs in fecal specimens.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10747162      PMCID: PMC86516     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  23 in total

1.  Capsid protein diversity among Norwalk-like viruses.

Authors:  J Green; J Vinje; C I Gallimore; M Koopmans; A Hale; D W Brown; J C Clegg; J Chamberlain
Journal:  Virus Genes       Date:  2000       Impact factor: 2.332

2.  Expression, self-assembly, and antigenicity of the Norwalk virus capsid protein.

Authors:  X Jiang; M Wang; D Y Graham; M K Estes
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

3.  Functional and topographical analyses of epitopes on the hemagglutinin (VP4) of the simian rotavirus SA11.

Authors:  J W Burns; H B Greenberg; R D Shaw; M K Estes
Journal:  J Virol       Date:  1988-06       Impact factor: 5.103

4.  Monoclonal capture antibody ELISA for respiratory syncytial virus: detection of individual viral antigens and determination of monoclonal antibody specificities.

Authors:  R M Hendry; B F Fernie; L J Anderson; E Godfrey; K McIntosh
Journal:  J Immunol Methods       Date:  1985-03-18       Impact factor: 2.303

5.  Sequence and genomic organization of Norwalk virus.

Authors:  X Jiang; M Wang; K Wang; M K Estes
Journal:  Virology       Date:  1993-07       Impact factor: 3.616

6.  Molecular characterization and expression of the capsid protein of a Norwalk-like virus recovered from a Desert Shield troop with gastroenteritis.

Authors:  J F Lew; A Z Kapikian; X Jiang; M K Estes; K Y Green
Journal:  Virology       Date:  1994-04       Impact factor: 3.616

7.  Norwalk virus infection of volunteers: new insights based on improved assays.

Authors:  D Y Graham; X Jiang; T Tanaka; A R Opekun; H P Madore; M K Estes
Journal:  J Infect Dis       Date:  1994-07       Impact factor: 5.226

8.  X-ray crystallographic structure of the Norwalk virus capsid.

Authors:  B V Prasad; M E Hardy; T Dokland; J Bella; M G Rossmann; M K Estes
Journal:  Science       Date:  1999-10-08       Impact factor: 47.728

9.  3'-terminal sequence of a small round structured virus (SRSV) in Japan.

Authors:  E T Utagawa; N Takeda; S Inouye; K Kasuga; S Yamazaki
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

10.  Sequence and genome organization of a human small round-structured (Norwalk-like) virus.

Authors:  P R Lambden; E O Caul; C R Ashley; I N Clarke
Journal:  Science       Date:  1993-01-22       Impact factor: 47.728

View more
  28 in total

1.  Multiple antigenic sites are involved in blocking the interaction of GII.4 norovirus capsid with ABH histo-blood group antigens.

Authors:  Gabriel I Parra; Eugenio J Abente; Carlos Sandoval-Jaime; Stanislav V Sosnovtsev; Karin Bok; Kim Y Green
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

2.  Evolutionary trace residues in noroviruses: importance in receptor binding, antigenicity, virion assembly, and strain diversity.

Authors:  Sugoto Chakravarty; Anne M Hutson; Mary K Estes; B V Venkataram Prasad
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  Porcine enteric caliciviruses: genetic and antigenic relatedness to human caliciviruses, diagnosis and epidemiology.

Authors:  Qiu-Hong Wang; Veronica Costantini; Linda J Saif
Journal:  Vaccine       Date:  2006-12-29       Impact factor: 3.641

4.  Mapping broadly reactive norovirus genogroup I and II monoclonal antibodies.

Authors:  Sue E Crawford; Nadim Ajami; Tracy Dewese Parker; Noritoshi Kitamoto; Katsuro Natori; Naokazu Takeda; Tomoyuki Tanaka; Baijun Kou; Robert L Atmar; Mary K Estes
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

5.  Characterization of cross-reactive norovirus-specific monoclonal antibodies.

Authors:  Baijun Kou; Sue E Crawford; Nadim J Ajami; Rita Czakó; Frederick H Neill; Tomoyuki N Tanaka; Noritoshi Kitamoto; Timothy G Palzkill; Mary K Estes; Robert L Atmar
Journal:  Clin Vaccine Immunol       Date:  2014-11-26

6.  Identification and characterization of a peptide affinity reagent for detection of noroviruses in clinical samples.

Authors:  Jennifer D Rogers; Nadim J Ajami; Bartlomiej G Fryszczyn; Mary K Estes; Robert L Atmar; Timothy Palzkill
Journal:  J Clin Microbiol       Date:  2013-04-03       Impact factor: 5.948

7.  Identification and characterization of antibody-binding epitopes on the norovirus GII.3 capsid.

Authors:  Jackie E Mahar; Nicole C Donker; Karin Bok; Gert H Talbo; Kim Y Green; Carl D Kirkwood
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

8.  Heterotypic humoral and cellular immune responses following Norwalk virus infection.

Authors:  Lisa C Lindesmith; Eric Donaldson; Juan Leon; Christine L Moe; Jeffrey A Frelinger; Robert E Johnston; David J Weber; Ralph S Baric
Journal:  J Virol       Date:  2009-12-09       Impact factor: 5.103

9.  A single-amino-acid substitution in the P2 domain of VP1 of murine norovirus is sufficient for escape from antibody neutralization.

Authors:  Vance P Lochridge; Michele E Hardy
Journal:  J Virol       Date:  2007-09-05       Impact factor: 5.103

10.  In vitro cell culture infectivity assay for human noroviruses.

Authors:  Timothy M Straub; Kerstin Höner zu Bentrup; Patricia Orosz-Coghlan; Alice Dohnalkova; Brooke K Mayer; Rachel A Bartholomew; Catherine O Valdez; Cynthia J Bruckner-Lea; Charles P Gerba; Morteza Abbaszadegan; Cheryl A Nickerson
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.